Premiere Educational Resource for Human Nuclear Receptor Information State College, PA (12/8/2016) INDIGO Biosciences, Inc. is pleased to announce the relaunch of the Nuclear Receptor Resource website. The NRR is a premier educational resource for information on the 48 human nuclear receptors. The NRR website has undergone a major redesign to make the site easierRead More
INDIGO Biosciences and Bertin Pharma Sign European Distribution Agreement
Ready-to-Use Nuclear Receptor Assay kits for over 20 disease states, including Cardiovascular and Metabolic Disease, Cancer, and Inflammation State College, PA (November 15, 2016) INDIGO Biosciences, the recognized industry-leader in Nuclear Receptor research, and Bertin Pharma have announced the completion of a European distribution agreement. Over 40 product references for studying nuclear receptors are nowRead More
INDIGO Offers Expansion of Industry-Leading FXR Assay
Meets industry demand for increased pre-clinical predictability. State College, PA (August 9, 2016) INDIGO Biosciences, the recognized industry leader in Nuclear Receptor research, announced the addition of the Mouse Farnesoid X Receptor (mFXR) assay to their FXR portfolio. This addition both complements INDIGO’s industry-leading human FXR assay and meets the demand for an expansion ofRead More
INDIGO Biosciences Raises $500 Thousand in Series B Funding
A Combination of Private Equity and Public Funds Invested State College, PA (August 2, 2016)– INDIGO Biosciences announced the completion of a $500,000 Series B financing round on June 28, 2016. The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) and AGSM, a private equity investment firm from Pittsburgh, Pennsylvania led this round. INDIGO’S latest financing willRead More
INDIGO Announces upcyte® Product Agreement
Agreement meets increasing demand for predictive liver toxicity models. State College, PA (July 19, 2016) INDIGO Biosciences, the recognized industry-leader in Nuclear Receptor research, and upcyte® technologies GmbH announced completion of a distribution Partnership. upcyte® technologies GmbH, based in Hampburg-Eppendorf, Germany, is a life science company specializing in controlled, scalable propagation and standardization of human primaryRead More
INDIGO Offers Next Generation in PXR Assay Systems
Expansion of Assay Critical to the Study of Metabolism and Drug-Drug Interactions State College, PA (June 7, 2016) INDIGO Biosciences, a recognized industry-leading provider of nuclear receptor products and services, announced today that it has completed development of the next generation of Pregnane X Receptor (PXR) technology. Previously available in kits and services for onlyRead More
Indigo Announces In Vitro Toxicology Platform
In vitro toxicology platform provides predictive model of liver toxicity. Aims to reduce the high rates of drug-induced liver damage State College, PA (May 4, 2016) INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has completed development of an in vitro toxicology platform, meeting the demand for predictive liver toxicity models. INDIGO’s inRead More
INDIGO Now Offering Mouse RORγ Assay Systems
New Assay Critical to the Study of Diabetes, Inflammation, and Metabolic Diseases State College, PA (April 26, 2016) INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has expanded its offerings to include Mouse RAR-related Orphan Receptor Gamma (nr1f3; mRORγ) kits and services. Mouse RORγ adds to INDIGO’s current RORγ product line: https://indigobiosciences.com/products/retinoid-receptor/h-rar-orphan-gamma/ Recent studiesRead More
INDIGO Now Offering LRH-1 Assay Systems
New Assay Critical to the Study of Diabetes, Pancreatic Cancer, and Metabolic Diseases State College, PA (January 20, 2016) INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has expanded its offerings to include liver homology receptor-1 (LRH-1) kits and services. LRH-1, also called NR5A2, is a nuclear receptor that is an essential regulatorRead More
INDIGO Now Offers Profiling of Genes Regulated by Nuclear Receptors
“Critical Step in Understanding the downstream genomic impact of interactions with nuclear receptors” State College, Pennsylvania, July 23, 2015 INDIGO Biosciences Inc., a recognized industry-leading provider of nuclear receptor products and services, announced today that it has expanded its service portfolio by offering analyses of nuclear receptor regulated genes. Gene expression is a widely used approachRead More